Thursday, January 24, 2019

Modulated Imaging Finds $7M For Tissue Health Assessment

Irvine-based Modulated Imaging, a developer of optical imaging products used for noninvasive assessment of tissue health, has raised $7M in a Series B funding, according to the company. The new funding was led by Pangaea Ventures and also included Fresenius Medical Care Ventures GmbH, Grey Sky Venture Partners, Mitsubishi UFJ Capital Co. Ltd and

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.